Cubist Systematic Strategies’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-232,473
Closed -$2.18M 2930
2025
Q1
$2.18M Buy
232,473
+97,123
+72% +$1.02M 0.01% 1366
2024
Q4
$1.24M Sell
135,350
-119,184
-47% -$876K 0.01% 1675
2024
Q3
$1.98M Buy
254,534
+28,031
+12% +$202K 0.01% 1434
2024
Q2
$1.37M Buy
226,503
+29,669
+15% +$183K 0.01% 1561
2024
Q1
$1.16M Sell
196,834
-71,238
-27% -$423K 0.01% 2057
2023
Q4
$2.1M Sell
268,072
-137,031
-34% -$950K 0.01% 1470
2023
Q3
$2.96M Buy
405,103
+349,532
+629% +$2.91M 0.02% 1093
2023
Q2
$580K Sell
55,571
-7,773
-12% -$74.8K ﹤0.01% 2301
2023
Q1
$655K Sell
63,344
-85,827
-58% -$1.1M ﹤0.01% 2496
2022
Q4
$2.05M Buy
149,171
+120,219
+415% +$1.67M 0.01% 1837
2022
Q3
$592K Sell
28,952
-78,000
-73% -$1.71M ﹤0.01% 3032
2022
Q2
$2.07M Buy
106,952
+26,674
+33% +$546K 0.01% 1827
2022
Q1
$1.73M Buy
80,278
+66,047
+464% +$1.5M 0.01% 1603
2021
Q4
$392K Sell
14,231
-67,262
-83% -$1.86M ﹤0.01% 2621
2021
Q3
$2.11M Buy
81,493
+26,855
+49% +$718K 0.03% 974
2021
Q2
$1.48M Buy
54,638
+21,013
+62% +$513K 0.02% 1294
2021
Q1
$787K Buy
33,625
+14,703
+78% +$297K 0.01% 1683
2020
Q4
$290K Sell
18,922
-11,873
-39% -$151K ﹤0.01% 2056
2020
Q3
$371K Buy
+30,795
New +$292K 0.01% 1903
2020
Q1
Sell
-82,654
Closed -$1.32M 2146
2019
Q4
$1.32M Buy
82,654
+68,507
+484% +$1.05M 0.02% 985
2019
Q3
$261K Sell
14,147
-7,151
-34% -$140K 0.01% 1627
2019
Q2
$419K Buy
+21,298
New +$434K 0.01% 1600
2017
Q1
Sell
-20,210
Closed -$341K 1619
2016
Q4
$341K Buy
+20,210
New +$337K 0.03% 887
2014
Q3
Sell
-7,487
Closed -$122K 1731
2014
Q2
$122K Buy
+7,487
New +$108K 0.01% 1293

Other funds holding ANGO

Cubist Systematic Strategies's ANGO Position: Q2 2025 in Review

Cubist Systematic Strategies sold out of AngioDynamics (ANGO) in Q2 2025, closing a stake of 232,473 shares — an estimated $2.18M sold.

Cubist Systematic Strategies first reported a position in ANGO in Q2 2014 and held it in 24 quarters. The position peaked at $2.96M in Q3 2023. 150 funds tracked by Wall St. Rank hold ANGO as of Q2 2025.

  • Cubist Systematic Strategies reported no remaining AngioDynamics position as of Q2 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 232,473 AngioDynamics shares in Q2 2025, an estimated $2.18M.
  • Cubist Systematic Strategies first reported a position in AngioDynamics in Q2 2014 and held it in 24 quarters.
  • Cubist Systematic Strategies's AngioDynamics position peaked at $2.96M in Q3 2023.
  • 150 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2025.

Based on Cubist Systematic Strategies's 13F filing for Q2 2025, filed 14 Aug 2025.